Resources
111 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 10/7/2019 (updated 3/25/2024)
Medication Assisted Treatment (MAT) for Opioid Use Disorder: Philosophical and Practical Considerations Webinar Presentation and Materials
Posted 12/20/2021 (updated 3/26/2024)
The Centers for Disease Control and Prevention (CDC) want greater awareness of adverse childhood experiences (ACEs) and their connection to high rates of overdose and suicide. This week they announced a new training webpage, UrgentRelatedPreventable.org, designed in collaboration with the American Public Health Association to provide background and talking points. The site explains how exposure to certain events and conditions in childhood have lasting effects on health, well-being, and prosperity far into adulthood. See Funding section below for a CDC effort to research the links between ACEs and substance use.
Posted 7/31/2023 (updated 3/26/2024)
In this webinar, the presenters discussed these numerous factors affecting social determinants of health (SDOH) and health outcomes, particularly in these communities, and strategies to address them.
Posted 8/11/2023 (updated 3/26/2024)
The Center of Excellence for Integrated Health Solutions (funded by Substance Abuse and Mental Health Services Administration and operated by the National Council for Mental Wellbeing) and the School-Based Health Alliance now has a guide to help mental health organizations have successful partnerships with schools as a way to help the mental health and substance use care for K-12 students. The guide provides information to consider, as well as resource recommendations.
Posted 8/8/2023 (updated 3/26/2024)
This webinar is an invaluable opportunity for health care professionals, policymakers, researchers, and anyone else interested in mental health and substance use interventions to learn about the latest research and innovative approaches in the field.
Posted 8/18/2023 (updated 3/26/2024)
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) held an event where health care professionals and federal partners discussed xylazine-related testing, treatment, and wound care. As the White House has deemed fentanyl adulterated with xylazine an emerging threat, it is important to identify and adapt to the rapidly changing practices of patient care.
Posted 8/15/2023 (updated 3/26/2024)
During this webinar, Aaron Ferguson and Dr. Janan Wyatt reviewed the evidence, including the cost benefit, of MOUD, and recent research findings on how regulatory changes affect patient experience.
Posted 8/25/2023 (updated 3/26/2024)
The National Institute for Health Care Management (NIHCM) provided interactive graphic reports on the trends in overdose deaths using the latest data. The interactive infographic shows the effects combined drugs, such as fentanyl and xylazine, have on overdoses.
Posted 9/8/2023 (updated 3/26/2024)
As suicide has become a major health concern in the United States, September 2023 is recognized as Suicide Prevention Month. The National Institute of Mental Health has put together a digital toolkit for Suicide Prevention Month to raise awareness. Resources are provided for multiple online platforms for the public to share which focus on recognizing the warning signs for suicide and how to get people the help they need.
Posted 9/8/2023 (updated 3/26/2024)
September 2023 is National Recovery Month and HRSA’s Office of Women’s Health has a toolkit to support organizations and health care providers that care for women living with opioid use disorder (OUD). The toolkit provides strategies to engage women with OUD, care coordination for support, and other resources.